Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 6, 2012, Pages 462-472

  Shafa, Mehdi ^a   Sjonnesen, Kirsten ^a   Yamashita, Akihiro ^a   Liu, Shiying ^a   Michalak, Marek ^b   Kallos, Michael S ^a   Rancourt, Derrick E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cell expansion; Induced pluripotent stem cells; Pluripotency; Stirred suspension bioreactor

Indexed keywords

AGGREGATES; BIOCONVERSION; BIOREACTORS; STEM CELLS; TISSUE CULTURE;

CELL EXPANSION; CELL THERAPY; EMBRYONIC STEM CELLS; IN-VITRO; INDUCED PLURIPOTENT STEM CELLS; LARGE-SCALES; LONG-TERM MAINTENANCES; PLURIPOTENCY; PLURIPOTENT; STIRRED SUSPENSION BIOREACTOR;

EXPANSION;

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR REX1; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE; CARTILAGE; CELL AGGREGATION; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; EMBRYOID BODY; GERM LAYER; HEART MUSCLE CELL; KARYOTYPE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL EXPANSION; STIRRED REACTOR; TERATOMA;

EID: 84860352889     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.450     Document Type: Article

References (34)

1. Baksh D, Davies JE, Zandstra PW. 2003; Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. Exp Hematol 31(8): 723-732.
2. Boland MJ, Hazen JL, Nazor KL, et al. 2009; Adult mice generated from induced pluripotent stem cells. Nature 461(7260): 91-94.
3. Cormier JT, zur Nieden NI, Rancourt DE, Kallos MS. 2006; Expansion of undifferentiated murine embryonic stem cells as aggregates in suspension culture bioreactors. Tissue Eng 12(11): 3233-3245.
4. Eridani S, Mazza U, Massaro P, La Targia ML, Maiolo AT, Mosca A. 1998; Cytokine effect on ex vivo expansion of haemopoietic stem cells from different human sources. Biotherapy 10(4): 295-298.
5. Fok EY, Zandstra PW. 2005; Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells 23(9): 1333-1342.
6. Gilbertson JA, Sen A, Behie LA, Kallos MS. 2006; Scaled-up production of mammalian neural precursor cell aggregates in computer-controlled suspension bioreactors. Biotechnol Bioeng 94(4): 783-792.
7. Guenther MG, Frampton GM, Soldner F, et al. 2010; Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7(2): 249-257.
8. Hanna J, Wernig M, Markoulaki S, et al. 2007; Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318(5858): 1920-1923.
9. Huangfu D, Osafune K, Maehr R, et al. 2008; Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26(11): 1269-1275.
10. Kallos MS, Behie LA. 1999; Inoculation and growth conditions for high-cell-density expansion of mammalian neural stem cells in suspension bioreactors. Biotechnol Bioeng 63(4): 473-483.
11. Kallos MS, Sen A, Behie LA. 2003; Large-scale expansion of mammalian neural stem cells: a review. Med Biol Eng Comput 41(3): 271-282.
12. Kang L, Wang J, Zhang Y, Kou Z, Gao S. 2009; iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 5(2): 135-138.
13. Kehoe DE, Lock LT, Parikh A, Tzanakakis ES. 2008; Propagation of embryonic stem cells in stirred suspension without serum. Biotechnol Prog 24(6): 1342-1352.
14. Kitamura T, Koshino Y, Shibata F, et al. 2003; Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 31(11): 1007-1014.
15. Kögler G, Callejas J, Sorg RV, Wernet P. 1998; An eight-fold ex vivo expansion of long-term culture-initiating cells from umbilical cord blood in stirred suspension cultures. Bone Marrow Transpl 21(suppl):( 3): S48-53.
16. Krawetz R, Taiani JT, Liu S, et al. 2010; Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng C Methods 16(4): 573-582.
17. Larijani MR, Seifinejad A, Pournasr B, et al. 2011; Long-term maintenance of undifferentiated human embryonic and induced pluripotent stem cells in suspension. Stem Cells Dev (in press).
18. Mohamet L, Lea ML, Ward CM. 2010; Abrogation of E-cadherin-mediated cellular aggregation allows proliferation of pluripotent mouse embryonic stem cells in shake flask bioreactors. PLoS One 5(9): e12921.
19. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. 2008; Generation of mouse induced pluripotent stem cells without viral vectors. Science 322(5903): 949-953.
20. Olmer R, Haase A, Merkert S, et al. 2010; Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res 5(1): 51-64.
21. Saha K, Jaenisch R. 2009; Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5(6): 584-595.
22. Smith KP, Luong MX, Stein GS. 2009; Pluripotency: toward a gold standard for human ES and iPS cells. J Cell Physiol 220(1): 21-29.
23. Suter DM, Cartier L, Bettiol E, et al. 2006; Rapid generation of stable transgenic embryonic stem cell lines using modular lentivectors. Stem Cells 24(3): 615-623.
24. Taiani JT, Krawetz RJ, Zur Nieden NI, et al. 2010; Reduced differentiation efficiency of murine embryonic stem cells in stirred suspension bioreactors. Stem Cells Dev 19(7): 989-998.
25. Takahashi K, Tanabe K, Ohnuki M, et al. 2007; Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5): 861-872.
26. Takahashi K, Yamanaka S. 2006; Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4): 663-676.
27. Woltjen K, Michael IP, Mohseni P, et al. 2009; piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766-770.
28. Yamanaka S. 2007; Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1(1): 39-49.
29. Yamashita A, Krawetz R, Rancourt DE. 2009; Loss of discordant cells during micro-mass differentiation of embryonic stem cells into the chondrocyte lineage. Cell Death Differ 16(2): 278-286.
30. Yamashita A, Nishikawa S, Rancourt DE. 2010a; Identification of five developmental processes during chondrogenic differentiation of embryonic stem cells. PLoS One 5(6): e10998.
31. Yamashita A, Nishikawa S, Rancourt DE. 2010b; Microenvironment modulates osteogenic cell lineage commitment in differentiated embryonic stem cells. PLoS One 5(3): e9663.
32. Yu J, Vodyanik MA, Smuga-Otto K, et al. 2007; Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858): 1917-1920.
33. Zhao XY, Li W, Lv Z, et al. 2009; iPS cells produce viable mice through tetraploid complementation. Nature 461(7260): 86-90.
34. zur Nieden NI, Cormier JT, Rancourt DE, et al. 2007; Embryonic stem cells remain highly pluripotent following long term expansion as aggregates in suspension bioreactors. J Biotechnol 129(3): 421-432.